Quoc Le-Nguyen
2022
In 2022, Quoc Le-Nguyen earned a total compensation of $1.5M as Chief Technical Operations Officer and Head of Quality at 89bio, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $206,600 |
|---|---|
| Option Awards | $234,080 |
| Salary | $435,000 |
| Stock Awards | $602,700 |
| Other | $12,841 |
| Total | $1,491,221 |
Le-Nguyen received $602.7K in stock awards, accounting for 40% of the total pay in 2022.
Le-Nguyen also received $206.6K in non-equity incentive plan, $234.1K in option awards, $435K in salary and $12.8K in other compensation.
Rankings
In 2022, Quoc Le-Nguyen's compensation ranked 2,235th out of 5,760 executives tracked by ExecPay. In other words, Le-Nguyen earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,235 out of 5,760 | 61st |
Division Manufacturing | 1,212 out of 3,136 | 61st |
Major group Chemicals And Allied Products | 532 out of 1,422 | 63rd |
Industry group Drugs | 489 out of 1,323 | 63rd |
Industry Pharmaceutical Preparations | 355 out of 969 | 63rd |
Source: SEC filing on April 24, 2023.
Le-Nguyen's colleagues
We found two more compensation records of executives who worked with Quoc Le-Nguyen at 89bio in 2022.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020